-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Recurrence are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Recurrence.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.
Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE
(2004) N Engl J Med 350: 443-50 - Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus.
Brash AR, Hickey DE, Graham TP, Stahlman MT, Oates JA, Cotton RB
(1981) N Engl J Med 305: 67-72 - Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
Robertson RM, Robertson D, Roberts LJ, Maas RL, FitzGerald GA, Friesinger GC, Oates JA
(1981) N Engl J Med 304: 998-1003 - Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.
Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE, Califf RM, Topol EJ
(1996) N Engl J Med 335: 1333-41 - Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P, Latino Study Group
(2009) N Engl J Med 360: 257-67 - Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, Imielinski M, Hu X, Ling S, Akbani R, Rosenberg M, Cibulskis C, Ramachandran A, Collisson EA, Kwiatkowski DJ, Lawrence MS, Weinstein JN, Verhaak RG, Wu CJ, Hammerman PS, Cherniack AD, Getz G, Cancer Genome Atlas Research Network, Artyomov MN, Schreiber R, Govindan R, Meyerson M
(2016) Nat Genet 48: 607-16 - Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.
Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, Yang W, Neale G, Cox NJ, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Willman CL, Bowman WP, Camitta BM, Carroll A, Reaman GH, Carroll WL, Loh M, Hunger SP, Pui CH, Evans WE, Relling MV
(2011) Nat Genet 43: 237-41 - p53 status and the efficacy of cancer therapy in vivo.
Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T
(1994) Science 266: 807-10 - Recurrent angiotensin-converting enzyme inhibitor--associated angioedema.
Brown NJ, Snowden M, Griffin MR
(1997) JAMA 278: 232-3 - Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.
Morgan DR, Torres J, Sexton R, Herrero R, Salazar-Martínez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio C, Lazcano-Ponce EC, Meza-Montenegro MM, Peña EM, Peña R, Correa P, Martínez ME, Chey WD, Valdivieso M, Anderson GL, Goodman GE, Crowley JJ, Baker LH
(2013) JAMA 309: 578-86 - Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.
Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S, Diaz-Flores E, Coram M, Shannon KM, Nolan GP, Loh ML
(2008) Cancer Cell 14: 335-43 - Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
Rothenberg ML, LaFleur B, Levy DE, Washington MK, Morgan-Meadows SL, Ramanathan RK, Berlin JD, Benson AB, Coffey RJ
(2005) J Clin Oncol 23: 9265-74 - When will melanoma vaccines be proven effective?
Sosman JA, Weeraratna AT, Sondak VK
(2004) J Clin Oncol 22: 387-9 - Combined small-cell and non-small-cell lung cancer.
Mangum MD, Greco FA, Hainsworth JD, Hande KR, Johnson DH
(1989) J Clin Oncol 7: 607-12 - Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.
Johnson DH, Greco FA, Strupp J, Hande KR, Hainsworth JD
(1990) J Clin Oncol 8: 1613-7 - Quality of life after breast cancer diagnosis and survival.
Epplein M, Zheng Y, Zheng W, Chen Z, Gu K, Penson D, Lu W, Shu XO
(2011) J Clin Oncol 29: 406-12 - [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD
(2005) J Clin Oncol 23: 1136-43 - Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.
Kelley MC, Gupta RK, Hsueh EC, Yee R, Stern S, Morton DL
(2001) J Clin Oncol 19: 1176-82 - Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.
Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD, Epstein J, van Hemert R, Erdem E, Hoering A, Crowley J, Ferris E, Hollmig K, van Rhee F, Zangari M, Pineda-Roman M, Mohiuddin A, Yaccoby S, Sawyer J, Angtuaco EJ
(2007) J Clin Oncol 25: 1121-8 - Acute pulmonary embolectomy: a contemporary approach.
Aklog L, Williams CS, Byrne JG, Goldhaber SZ
(2002) Circulation 105: 1416-9 - Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.
Harrison DG, Ferguson DW, Collins SM, Skorton DJ, Ericksen EE, Kioschos JM, Marcus ML, White CW
(1984) Circulation 69: 991-9 - Calmodulin mutations associated with recurrent cardiac arrest in infants.
Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, Papagiannis J, Feldkamp MD, Rathi SG, Kunic JD, Pedrazzini M, Wieland T, Lichtner P, Beckmann BM, Clark T, Shaffer C, Benson DW, Kääb S, Meitinger T, Strom TM, Chazin WJ, Schwartz PJ, George AL
(2013) Circulation 127: 1009-17 - Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project.
Pierce JP, Patterson RE, Senger CM, Flatt SW, Caan BJ, Natarajan L, Nechuta SJ, Poole EM, Shu XO, Chen WY
(2014) J Natl Cancer Inst 106: djt359 - Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
Nakamura Y, Ratain MJ, Cox NJ, McLeod HL, Kroetz DL, Flockhart DA
(2012) J Natl Cancer Inst 104: 1264; author reply 1266-8 - Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.
Parvez B, Vaglio J, Rowan S, Muhammad R, Kucera G, Stubblefield T, Carter S, Roden D, Darbar D
(2012) J Am Coll Cardiol 60: 539-45 - Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD, Grosh WW, Burnett LS, Jones HW, Wolff SN, Greco FA
(1988) Ann Intern Med 108: 165-70 - The developmental trajectory of pediatric asthma in 3- to-10-year-olds.
Wu P, Carroll KN, Gebretsadik T, Dupont WD, Mitchel EF, Hartert TV
(2012) J Allergy Clin Immunol 129: 1397-8 - Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH.
Ohki T, Tateishi R, Shiina S, Goto E, Sato T, Nakagawa H, Masuzaki R, Goto T, Hamamura K, Kanai F, Yoshida H, Kawabe T, Omata M
(2009) Gut 58: 839-44 - ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK
(2014) Eur Urol 66: 77-84 - Reply to Alexander S. Parker, Brad C. Leibovich, Jeanette E. Eckel-Passow, John C. Cheville's letter to the editor re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.
Rathmell WK, Brooks SA, Parker JS, Nielsen ME
(2014) Eur Urol 66: e92 - ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.
Kamat AM, Hegarty PK, Gee JR, Clark PE, Svatek RS, Hegarty N, Shariat SF, Xylinas E, Schmitz-Dräger BJ, Lotan Y, Jenkins LC, Droller M, van Rhijn BW, Karakiewicz PI, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012
(2013) Eur Urol 63: 4-15 - Follow-up of residual disease using metaphase-FISH in patients with acute lymphoblastic leukemia in remission.
El-Rifai W, Ruutu T, Vettenranta K, Elonen E, Saarinen UM, Volin L, Knuutila S
(1997) Leukemia 11: 633-8 - Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence.
Soroida Y, Ohkawa R, Nakagawa H, Satoh Y, Yoshida H, Kinoshita H, Tateishi R, Masuzaki R, Enooku K, Shiina S, Sato T, Obi S, Hoshino T, Nagatomo R, Okubo S, Yokota H, Koike K, Yatomi Y, Ikeda H
(2012) J Hepatol 57: 330-6 - Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.
Crowe JE, Murphy BR, Chanock RM, Williamson RA, Barbas CF, Burton DR
(1994) Proc Natl Acad Sci U S A 91: 1386-90 - Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome.
Weitkamp JH, Tang YW, Haas DW, Midha NK, Crowe JE
(2000) Clin Infect Dis 31: 1183-7 - Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia.
Peters TR, Brumbaugh DE, Lawton AR, Crowe JE
(2000) Clin Infect Dis 31: 1287-8 - Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist.
Solomon DH, Rassen JA, Kuriya B, Chen L, Harrold LR, Graham DJ, Lewis JD, Lii J, Liu L, Griffin MR, Curtis JR
(2013) Ann Rheum Dis 72: 1813-8 - Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.
Yang JJ, Cheng C, Devidas M, Cao X, Campana D, Yang W, Fan Y, Neale G, Cox N, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Bowman WP, Camitta B, Reaman GH, Carroll WL, Willman CL, Hunger SP, Evans WE, Pui CH, Loh M, Relling MV
(2012) Blood 120: 4197-204 - A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
Shaughnessy JD, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, Stewart JP, Kordsmeier B, Randolph C, Williams DR, Xiao Y, Xu H, Epstein J, Anaissie E, Krishna SG, Cottler-Fox M, Hollmig K, Mohiuddin A, Pineda-Roman M, Tricot G, van Rhee F, Sawyer J, Alsayed Y, Walker R, Zangari M, Crowley J, Barlogie B
(2007) Blood 109: 2276-84 - Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.
Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK, Shaw PJ, Haight AE, Grimley M, Grupp SA, Kletzel M, Kadota R
(2009) Blood 114: 1429-36
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
